🇺🇸 FDA
Pipeline program

Rybelsus 7 mg tablets, Kerendia 20 mg film-coated tablets, Rybelsus 3 mg tablets, Rybelsus 14 mg tablets

17456

Phase 2 small_molecule active

Quick answer

Rybelsus 7 mg tablets, Kerendia 20 mg film-coated tablets, Rybelsus 3 mg tablets, Rybelsus 14 mg tablets for Chronic Kidney Disease is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Chronic Kidney Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials